Francesco Infarinato is a bioengineer with a Ph.D. in Neurophysiology (2011). He served as an adjunct professor in Biomedical Data and Signal Processing at Sapienza University of Rome until 2020. Currently, he leads the Rehabilitation Bioengineering Laboratory of IRCCS San Raffaele in Rome and coordinates the Clinical Engineering Unit for the San Raffaele Group. His work mainly focuses on advanced biomedical data and signal analysis in translational rehabilitation research, device design, and biomedical device management. He has served as Project Manager and Principal Investigator on numerous international and national projects on digital therapeutics, telemonitoring and telerehabilitation.
- 11:15 am
- - 12:30 pm
Wednesday, December 4th, 2024
Despite the potential of digital health and innovative therapies to revolutionize healthcare, adoption and development remain complex challenges. What is the current state of the regulatory and reimbursement pathways for digital health and medicine? What to expect from the EHDS? What initiatives are underway to promote interoperability, data sharing and access to secondary use of health data? Have reimbursement processes like DiGA or PECAN proved their effectiveness in deploying digital health solutions? What are the key components of successful value proposition and revenue model for digital health innovations? How do investment strategies of VCs and big players influence the development and adoption of digital health technologies? How can further collaboration between healthcare providers, regulators, industry, and patients accelerate their adoption?
